159 related articles for article (PubMed ID: 32540447)
21. Italian multicentre study for application of a diagnostic algorithm in autoantibody testing for autoimmune rheumatic disease: conclusive results.
Bonaguri C; Melegari A; Ballabio A; Parmeggiani M; Russo A; Battistelli L; Aloe R; Trenti T; Lippi G
Autoimmun Rev; 2011 Nov; 11(1):1-5. PubMed ID: 21741498
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of antinuclear antibodies by indirect immunofluorescence and line immunoassay methods': four years' data from Turkey.
Sener AG; Afsar I; Demirci M
APMIS; 2014 Dec; 122(12):1167-70. PubMed ID: 24735346
[TBL] [Abstract][Full Text] [Related]
23. Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases.
Mahler M; Hanly JG; Fritzler MJ
Autoimmun Rev; 2012 Jul; 11(9):642-5. PubMed ID: 22100330
[TBL] [Abstract][Full Text] [Related]
24. Determination of Specificity and Pattern of Antinuclear Antibodies (ANA) in Systemic Rheumatic Disease Patients Positive for ANA Testing.
Tipu HN; Bashir MM
J Coll Physicians Surg Pak; 2018 Jan; 28(1):40-43. PubMed ID: 29290190
[TBL] [Abstract][Full Text] [Related]
25. Automated antinuclear immunofluorescence antibody analysis is a reliable approach in routine clinical laboratories.
Zheng B; Li E; Zhu H; Lu J; Shi X; Zhang J; Li M
Clin Chem Lab Med; 2017 Oct; 55(12):1922-1930. PubMed ID: 28467309
[TBL] [Abstract][Full Text] [Related]
26. Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective.
Damoiseaux J; Andrade LEC; Carballo OG; Conrad K; Francescantonio PLC; Fritzler MJ; Garcia de la Torre I; Herold M; Klotz W; Cruvinel WM; Mimori T; von Muhlen C; Satoh M; Chan EK
Ann Rheum Dis; 2019 Jul; 78(7):879-889. PubMed ID: 30862649
[TBL] [Abstract][Full Text] [Related]
27. Subgroups of canine antinuclear antibodies in relation to laboratory and clinical findings in immune-mediated disease.
Hansson-Hamlin H; Lilliehöök I; Trowald-Wigh G
Vet Clin Pathol; 2006 Dec; 35(4):397-404. PubMed ID: 17123245
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic accuracy of ELISA methods as an alternative screening test to indirect immunofluorescence for the detection of antinuclear antibodies. Evaluation of five commercial kits.
Tonuttia E; Bassetti D; Piazza A; Visentini D; Poletto M; Bassetto F; Caciagli P; Villalta D; Tozzoli R; Bizzaro N
Autoimmunity; 2004 Mar; 37(2):171-6. PubMed ID: 15293886
[TBL] [Abstract][Full Text] [Related]
29. Reconstructing a 3-dimensional image of the results of antinuclear antibody testing by indirect immunofluorescence.
Murai R; Yamada K; Tanaka M; Kuribayashi K; Kobayashi D; Tsuji N; Watanabe N
J Immunol Methods; 2013 Jan; 387(1-2):312-6. PubMed ID: 23073364
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of a Computer-Aided Microscope System and Its Anti-Nuclear Antibody Test Kit for Indirect Immunofluorescence Assay].
Hayashi N; Saegusa J; Uto K; Oyabu C; Saito T; Sato I; Kawano S; Kumagai S
Rinsho Byori; 2016 Feb; 64(2):142-51. PubMed ID: 27311277
[TBL] [Abstract][Full Text] [Related]
31. How to report the antinuclear antibodies (anti-cell antibodies) test on HEp-2 cells: guidelines from the ICAP initiative.
von Mühlen CA; Garcia-De La Torre I; Infantino M; Damoiseaux J; Andrade LEC; Carballo OG; Conrad K; Francescantonio PLC; Fritzler MJ; Herold M; Klotz W; de Melo Cruvinel W; Mimori T; Satoh M; Musset L; Chan EKL
Immunol Res; 2021 Dec; 69(6):594-608. PubMed ID: 34625914
[TBL] [Abstract][Full Text] [Related]
32. Autoantibodies Against DFS70/LEDGF Exclusion Markers for Systemic Autoimmune Rheumatic Diseases (SARD).
Seelig CA; Bauer O; Seelig HP
Clin Lab; 2016; 62(4):499-517. PubMed ID: 27215068
[TBL] [Abstract][Full Text] [Related]
33. Combining immunofluorescence with immunoblot assay improves the specificity of autoantibody testing for myositis.
Infantino M; Tampoia M; Fabris M; Alessio MG; Previtali G; Pesce G; Deleonardi G; Porcelli B; Musso M; Grossi V; Benucci M; Manfredi M; Bizzaro N
Rheumatology (Oxford); 2019 Jul; 58(7):1239-1244. PubMed ID: 30726990
[TBL] [Abstract][Full Text] [Related]
34. Clinical use of anti-DFS70 autoantibodies.
Kang SY; Lee WI; Kim MH; La Jeon Y
Rheumatol Int; 2019 Aug; 39(8):1423-1429. PubMed ID: 30972541
[TBL] [Abstract][Full Text] [Related]
35. Canine antinuclear antibodies: comparison of immunofluorescence staining patterns and precipitin reactivity.
Hansson H; Karlsson-Parra A
Acta Vet Scand; 1999; 40(3):205-12. PubMed ID: 10605137
[TBL] [Abstract][Full Text] [Related]
36. [Investigation of antinuclear antibodies in chronic hepatitis B patients].
Şener AG; Aydın N; Ceylan C; Kırdar S
Mikrobiyol Bul; 2018 Oct; 52(4):425-430. PubMed ID: 30522427
[TBL] [Abstract][Full Text] [Related]
37. [International Consensus on Antinuclear Antibody Patterns in Portugal].
Sousa MJ; Neves E; Figueiras O; Cruz AP; Fernandes I; Mendes A; Santos MC; Cunha R; Magueijo L; Pratas C; Miranda A; Ribeiro R
Acta Med Port; 2021 May; 34(5):347-354. PubMed ID: 34253282
[TBL] [Abstract][Full Text] [Related]
38. Progression of nailfold microvascular damage and antinuclear antibody pattern in systemic sclerosis.
Sulli A; Ruaro B; Smith V; Pizzorni C; Zampogna G; Gallo M; Cutolo M
J Rheumatol; 2013 May; 40(5):634-9. PubMed ID: 23457379
[TBL] [Abstract][Full Text] [Related]
39. Application of anti-DFS70 antibody and specific autoantibody test algorithms to patients with the dense fine speckled pattern on HEp-2 cells.
Lee H; Kim Y; Han K; Oh EJ
Scand J Rheumatol; 2016; 45(2):122-8. PubMed ID: 26643611
[TBL] [Abstract][Full Text] [Related]
40. Laboratory and clinical practices in antinuclear antibody detection and related antigens: recommendations from a Spanish multicentre survey.
Martinez-Martinez L; Irure-Ventura J; Jurado A; Roy G; Montes MA; Barrios Y; Rodríguez-Bayona B; Vergara E; Prada Á; Rojo R; Vargas ML;
Immunol Res; 2023 Oct; 71(5):749-759. PubMed ID: 37195550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
